Introduction It has been well established that pulmonary function can be altered by cardiac disease.' Conversely, pulmonary pathology may result in a b nonnal cardiac function and anatomy. Pulmonary function testing offers a simple method of quantitating and following these changes. The purpose of this paper is to illustrate the value of such measurements in cardiovascular disease. This is particularly useful in evaluating the effects of various modalities of therapy.